4.6 Article

MicroRNAs in Kidney Disease: An Emerging Understanding

期刊

AMERICAN JOURNAL OF KIDNEY DISEASES
卷 61, 期 5, 页码 798-808

出版社

W B SAUNDERS CO-ELSEVIER INC
DOI: 10.1053/j.ajkd.2012.09.018

关键词

Kidney disease; microRNA; renal cell carcinoma; kidney development; kidney function; tumor markers; polycystic kidney disease; diabetes; hypertension

资金

  1. Canadian Institute of Health Research (CIHR) [DC01N0GP]
  2. Canadian Cancer Society (CCS) [20185]
  3. Ministry of Research and Innovation, Government of Ontario
  4. Kidney Foundation of Canada
  5. Cancer Research Society

向作者/读者索取更多资源

MicroRNAs (miRNAs) are short noncoding RNA molecules that function by negatively regulating the expression of their target genes in a tightly controlled manner. Accumulating evidence, based in part on effects seen after miRNA overexpression and/or knockdown, points to the critical involvement of miRNAs in kidney function in health and disease. In this review, we provide a quick overview of the biogenesis of miRNAs and their potential involvement in kidney development and normal function. We also discuss the current literature that has begun to uncover the role of miRNAs in the pathogenesis of kidney diseases, including diabetic nephropathy, hypertension, glomerulonephritis, and cancer. As such, miRNAs have potential utility in the clinical realm as disease biomarkers. Moreover, miRNAs represent an attractive therapeutic target for a number of kidney diseases. We close by discussing a number of potential challenges that face the field of miRNA research and clinical use. Am J Kidney Dis. 61(5): 798-808. Crown Copyright 2013 Published by Elsevier Inc. on behalf of the National Kidney Foundation, Inc. All rights reserved.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Pathology

Low Expression of miR-126 Is a Prognostic Marker for Metastatic Clear Cell Renal Cell Carcinoma

Heba W. Z. Khella, Andreas Scorilas, Roy Mozes, Lorna Mirham, Evi Lianidou, Sergey N. Krylov, Jason Y. Lee, Michael Ordon, Robert Stewart, Michael A. S. Jewett, George M. Youseff

AMERICAN JOURNAL OF PATHOLOGY (2015)

Article Pathology

miR-210 Is a Prognostic Marker in Clear Cell Renal Cell Carcinoma

Sara Samaan, Heba W. Z. Khella, Andrew Girgis, Andreas Scorilas, Evi Lianidou, Manal Gabril, Sergey N. Krylov, Michael Jewett, Georg A. Bjarnason, La El-said, George M. Yousef

JOURNAL OF MOLECULAR DIAGNOSTICS (2015)

Article Biotechnology & Applied Microbiology

miR-221/222 Are Involved in Response to Sunitinib Treatment in Metastatic Renal Cell Carcinoma

Heba W. Z. Khella, Henriett Butz, Qiang Ding, Fabio Rotondo, Kenneth R. Evans, Peter Kupchak, Moyez Dharsee, Ashraf Latif, Maria D. Pasic, Evi Lianidou, Georg A. Bjarnason, George M. Yousef

MOLECULAR THERAPY (2015)

Article Oncology

miRNA-target network reveals miR-124as a key miRNA contributing to clear cell renal cell carcinoma aggressive behaviour by targeting CAV1 and FLOT1

Henriett Butz, Peter M. Szabo, Heba W. Z. Khella, Roy Nofech-Mozes, Attila Patocs, George M. Yousef

ONCOTARGET (2015)

Article Oncology

MicroRNA-194 is a Marker for Good Prognosis in Clear Cell Renal Cell Carcinoma

Roy Nofech-Mozes, Heba W. Z. Khella, Andreas Scorilas, Leza Youssef, Sergey N. Krylov, Evi Lianidou, Konstantinos G. Sidiropoulos, Manal Gabril, Andrew Evans, George M. Yousef

CANCER MEDICINE (2016)

Article Pathology

miR-10b is a prognostic marker in clear cell renal cell carcinoma

Heba W. Z. Khella, Nicole Daniel, Leza Youssef, Andreas Scorilas, Roy Nofech-Mozes, Lorna Mirham, Sergey N. Krylov, Evi Liandeau, Adriana Krizova, Antonio Finelli, Yufeng Cheng, George M. Yousef

JOURNAL OF CLINICAL PATHOLOGY (2017)

Article Oncology

A miRNA-based classification of renal cell carcinoma subtypes by PCR and in situ hybridization

Ashley Di Meo, Rola Saleeb, Samantha J. Wala, Heba W. Khella, Qiang Ding, Haiyan Zhai, Kalra Krishan, Adriana Krizova, Manal Gabril, Andrew Evans, Fadi Brimo, Maria D. Pasic, Antonio Finelli, Eleftherios P. Diamandis, George M. Yousef

ONCOTARGET (2018)

Article Oncology

miR-192, miR-194 and miR-215: a convergent microRNA network suppressing tumor progression in renal cell carcinoma

H. W. Z. Khella, M. Bakhet, G. Allo, M. A. S. Jewett, A. H. Girgis, A. Latif, H. Girgis, I. Von Both, G. A. Bjarnason, G. M. Yousef

CARCINOGENESIS (2013)

Article Pathology

The Clinical Utility of miR-21 as a Diagnostic and Prognostic Marker for Renal Cell Carcinoma

Hala Faragalla, Youssef M. Youssef, Andreas Scorilas, Bishoy Khalil, Nicole M. A. White, Salvador Mejia-Guerrero, Heba Khella, Michael A. S. Jewett, Andrew Evans, Zsuzsanna Lichner, Georg Bjarnason, Linda Sugar, Magdy I. Attalah, George M. Yousef

JOURNAL OF MOLECULAR DIAGNOSTICS (2012)

Article Oncology

Translational research: Empowering the role of pathologists and cytopathologists

Heba W. Z. Khella, George M. Yousef

CANCER CYTOPATHOLOGY (2018)

Article Oncology

The miR-200 family as prognostic markers in clear cell renal cell carcinoma

Rola Saleeb, Sung Sun Kim, Qiang Ding, Andreas Scorilas, Sicheng Lin, Heba W. Z. Khella, Carl Boulos, Gena Ibrahim, George M. Yousef

UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS (2019)

Article Biology

Clinical Biomarker of Sterile Inflammation, HMGB1, in Patients with Chronic Non-Specific Low Back Pain: A Pilot Cross-Sectional Study

Julita A. Teodorczyk-Injeyan, Heba Khella, H. Stephen Injeyan

Summary: The study investigates the role of HMGB1 in chronic non-specific LBP and finds that the levels of extracellular HMGB1 are elevated in LBP patients. It also shows a correlation between HMGB1 levels and pain intensity.

LIFE-BASEL (2023)

Article Medicine, Research & Experimental

Betanin improves motor function and alleviates experimental Parkinsonism via downregulation of TLR4/MyD88/NF-?B pathway: Molecular docking and biological investigations

Mohamed H. ElSayed, Huda M. Atif, Mohamed Ahmed Eladl, Samah M. Elaidy, Ahmed M. N. Helaly, Fatma Azzahraa Hisham, Noha E. Farag, Noura M. S. Osman, Afaf T. Ibrahiem, Heba W. Z. Khella, Shymaa E. Bilasy, Marzough Aziz Albalawi, Mohamed A. Helal, Wafa Ali Alzlaiq, Sawsan A. Zaiton

Summary: In this study, the neuroprotective effect of betanin was investigated in a rotenone-induced Parkinson-like mouse model. Results showed that betanin improved motor function and reduced oxidative stress and inflammation. Therefore, betanin has the potential to be used as a therapeutic agent for Parkinson's disease.

BIOMEDICINE & PHARMACOTHERAPY (2023)

Article Urology & Nephrology

Exosomal MicroRNAs Are Diagnostic Biomarkers and Can Mediate Cell-Cell Communication in Renal Cell Carcinoma

Henriett Butz, Roy Nofech-Mozes, Qiang Ding, Heba W. Z. Khella, Peter M. Szabo, Michael Jewett, Antonio Finelli, Jason Lee, Michael Ordon, Robert Stewart, Sergey Krylov, George M. Yousef

EUROPEAN UROLOGY FOCUS (2016)

暂无数据